{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T18:55:33Z","timestamp":1790016933988,"version":"4.0.1"},"reference-count":84,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002924","name":"Federaci\u00f3n Espa\u00f1ola de Enfermedades Raras","doi-asserted-by":"publisher","award":["ICI21\/00016"],"award-info":[{"award-number":["ICI21\/00016"]}],"id":[{"id":"10.13039\/501100002924","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016028","name":"Ag\u00e8ncia Valenciana de la Innovaci\u00f3","doi-asserted-by":"publisher","award":["AVI-GVA COVID-19-68"],"award-info":[{"award-number":["AVI-GVA COVID-19-68"]}],"id":[{"id":"10.13039\/501100016028","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016028","name":"Ag\u00e8ncia Valenciana de la Innovaci\u00f3","doi-asserted-by":"publisher","award":["BIO21\/ COV\/030"],"award-info":[{"award-number":["BIO21\/ COV\/030"]}],"id":[{"id":"10.13039\/501100016028","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016028","name":"Ag\u00e8ncia Valenciana de la Innovaci\u00f3","doi-asserted-by":"publisher","award":["GVA-COVI19\/2021\/047"],"award-info":[{"award-number":["GVA-COVI19\/2021\/047"]}],"id":[{"id":"10.13039\/501100016028","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016028","name":"Ag\u00e8ncia Valenciana de la Innovaci\u00f3","doi-asserted-by":"publisher","award":["JDRF 2-SRA-2019-837"],"award-info":[{"award-number":["JDRF 2-SRA-2019-837"]}],"id":[{"id":"10.13039\/501100016028","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023479","name":"CRIS Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023479","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008061","name":"Fundaci\u00f3n Mutua Madrile\u00f1a","doi-asserted-by":"publisher","award":["AP176182020"],"award-info":[{"award-number":["AP176182020"]}],"id":[{"id":"10.13039\/100008061","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.jcyt.2023.10.002","type":"journal-article","created":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T07:35:58Z","timestamp":1698564958000},"page":"25-35","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Results of phase 2 randomized multi-center study to evaluate the safety and efficacy of infusion of memory T cells as adoptive therapy in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia and\/or lymphopenia (RELEASE NCT04578210)"],"prefix":"10.1016","volume":"26","author":[{"given":"Cristina","family":"Ferreras","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Hern\u00e1ndez-Blanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Mart\u00edn-Quir\u00f3s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karima","family":"Al-Akioui-Sanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Mora-Rillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F\u00e1tima","family":"Ib\u00e1\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"D\u00edaz-Almir\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Cano-Ochando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Lozano-Ojalvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Jim\u00e9nez-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Goterris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"S\u00e1nchez-Zapardiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"de Paz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Guerra-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Queiruga-Parada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Luisa","family":"Briones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Ruz-Caracuel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto M.","family":"Borobia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio J.","family":"Carcas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dolores","family":"Planelles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Luis","family":"Vicario","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel \u00c1ngel","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Balas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Llano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Llorente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1lvaro","family":"del Balzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Ca\u00f1ada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel \u00c1ngel","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Elena","family":"Calvin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Arenas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebeca","family":"P\u00e9rez de Diego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Eguiz\u00e1bal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernat","family":"Soria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Solano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"P\u00e9rez-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcyt.2023.10.002_bib0001","unstructured":"World Health Organization. Weekly epidemiological update on COVID-19. Available from: https:\/\/www.who.int\/publications\/m\/item\/weekly-epidemiological-update-on-covid-19---1-september-2023."},{"key":"10.1016\/j.jcyt.2023.10.002_bib0002","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1001\/jama.2020.2648","article-title":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention","volume":"323","author":"Wu","year":"2020","journal-title":"JAMA."},{"key":"10.1016\/j.jcyt.2023.10.002_bib0003","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.semerg.2020.06.013","article-title":"Analysis of fatality rates case of SARS-CoV-2 infection in the autonomous communities of Spain","volume":"46","author":"Mart\u00edn-S\u00e1nchez","year":"2020","journal-title":"Semergen"},{"key":"10.1016\/j.jcyt.2023.10.002_bib0004","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2147\/CEOR.S338225","article-title":"Economic burden of COVID-19: a systematic review","volume":"14","author":"Richards","year":"2022","journal-title":"Clin. Outcomes Res."},{"key":"10.1016\/j.jcyt.2023.10.002_bib0005","first-page":"1","article-title":"Potential therapeutic options for COVID\u201119\u00a0: an update on current evidence","author":"Niknam","year":"2022","journal-title":"Eur. J. Med. Res."},{"key":"10.1016\/j.jcyt.2023.10.002_bib0006","article-title":"Remdesivir for the treatment of COVID-19\u2014preliminary report","volume":"1\u201312","author":"Beigel","year":"2020","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.jcyt.2023.10.002_bib0007","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with COVID-19","volume":"384","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"6508","key":"10.1016\/j.jcyt.2023.10.002_bib0008","doi-asserted-by":"crossref","first-page":"eabc8511","DOI":"10.1126\/science.abc8511","article-title":"Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications","volume":"369","author":"Mathew","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.jcyt.2023.10.002_bib0009","doi-asserted-by":"crossref","unstructured":"Schwarzkopf, S. et al. Cellular immunity in COVID-19 convalescents with PCR-confirmed infection but with undetectable SARS-CoV-2-specific IgG. Emerg. Infect. Dis. 2021;27:122\u20139.","DOI":"10.3201\/eid2701.203772"},{"issue":"1","key":"10.1016\/j.jcyt.2023.10.002_bib0010","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41392-020-0148-4","article-title":"Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study","volume":"5","author":"Tan","year":"2020","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.jcyt.2023.10.002_bib0011","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1172\/JCI137244","article-title":"Clinical and immunological features of severe and moderate coronavirus disease 2019","volume":"130","author":"Chen","year":"2020","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jcyt.2023.10.002_bib0012","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.healun.2020.03.012","article-title":"COVID-19 illness in native and immunosuppressed states: a clinical\u2013therapeutic staging proposal","volume":"39","author":"Siddiqi","year":"2020","journal-title":"J. Hear. Lung Transplant."},{"key":"10.1016\/j.jcyt.2023.10.002_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.103920","article-title":"Mesenchymal stem cell treatment for COVID-19","volume":"77","author":"Xu","year":"2022","journal-title":"eBioMedicine"},{"key":"10.1016\/j.jcyt.2023.10.002_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.108655","article-title":"International immunopharmacology COVID-19 immunotherapy: treatment based on the immune cell-mediated approaches","volume":"107","author":"Zavvar","year":"2022","journal-title":"Int. Immunopharmacol."},{"issue":"2","key":"10.1016\/j.jcyt.2023.10.002_bib0015","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/s41551-018-0325-8","article-title":"Manufacturing of primed mesenchymal stromal cells for therapy","volume":"3","author":"Yin","year":"2019","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.jcyt.2023.10.002_bib0016","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abg5995","article-title":"Cell therapy strategies for COVID-19: current approaches and potential applications","volume":"7","author":"Zaki","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jcyt.2023.10.002_bib0017","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/d41586-021-01557-z","article-title":"A long-term perspective on immunity to COVID","volume":"595","author":"Radbruch","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.jcyt.2023.10.002_bib0018","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-021-25312-0","article-title":"Protective humoral and cellular immune responses to SARS-CoV-2 persist up to 1 year after recovery","volume":"12","author":"Feng","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jcyt.2023.10.002_bib0019","doi-asserted-by":"crossref","unstructured":"Cox RJ, Brokstad KA. Not just antibodies: B cells and T cells mediate immunity to COVID-19. Nat. Rev. Immunol. 1\u20132. https:\/\/doi.org\/10.1038\/s41577-020-00436-4.","DOI":"10.1038\/s41577-020-00436-4"},{"key":"10.1016\/j.jcyt.2023.10.002_bib0020","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/s41409-017-0035-y","article-title":"Low-dose donor memory T-cell infusion after TCR alpha\/beta depleted unrelated and haploidentical transplantation: results of a pilot trial","volume":"53","author":"Maschan","year":"2018","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2023.10.002_bib0021","article-title":"Immunological and clinical impact of manipulated and unmanipulated DLI after allogeneic stem cell transplantation of AML patients","volume":"9","author":"Greiner","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.jcyt.2023.10.002_bib0022","doi-asserted-by":"crossref","unstructured":"Bleakley M, Sehgal A, Seropian S, Biernacki MA. Naive T-cell depletion to prevent chronic graft-versus-host disease. J. Clin. Oncol. 2021;40:1174\u201386.","DOI":"10.1200\/JCO.21.01755"},{"issue":"5","key":"10.1016\/j.jcyt.2023.10.002_bib0023","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.bbmt.2014.01.032","article-title":"Engineering human peripheral blood stem cell grafts that are depleted of naive T cells and retain functional pathogen-specific memory T cells","volume":"20","author":"Bleakley","year":"2014","journal-title":"Biol. Blood Marrow Transplant"},{"issue":"5","key":"10.1016\/j.jcyt.2023.10.002_bib0024","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/s41409-019-0750-7","article-title":"Improved survival rate in T-cell depleted haploidentical hematopoietic cell transplantation over the last 15 years at a single institution","volume":"55","author":"Mamcarz","year":"2020","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1016\/j.jcyt.2023.10.002_bib0025","doi-asserted-by":"crossref","DOI":"10.1111\/tid.12823","article-title":"Selective T-cell depletion targeting CD45RA reduces viremia and enhances early T-cell recovery compared with CD3-targeted T-cell depletion","volume":"20","author":"Triplett","year":"2018","journal-title":"Transpl. Infect. Dis."},{"issue":"7","key":"10.1016\/j.jcyt.2023.10.002_bib0026","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1038\/bmt.2015.139","article-title":"Rapid memory T-cell reconstitution recapitulating CD45RA-depleted haploidentical transplant graft content in patients with hematologic malignancies","volume":"50","author":"Triplett","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2023.10.002_bib0027","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1016\/j.bbmt.2018.07.016","article-title":"Unexpected high incidence of human herpesvirus-6 encephalitis after naive T cell\u2013depleted graft of haploidentical stem cell transplantation in pediatric patients","volume":"24","author":"Sisinni","year":"2018","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.jcyt.2023.10.002_bib0028","doi-asserted-by":"crossref","first-page":"478.e1","DOI":"10.1016\/j.jtct.2021.03.010","article-title":"Feasibility and efficacy of CD45RA+ depleted donor lymphocytes infusion after haploidentical transplantation with post-transplantation cyclophosphamide in patients with hematological malignancies","volume":"27","author":"Castagna","year":"2021","journal-title":"Transplant. Cell. Ther."},{"key":"10.1016\/j.jcyt.2023.10.002_bib0029","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/s41409-020-0991-5","article-title":"Phase I dose escalation study of naive T-cell depleted donor lymphocyte infusion following allogeneic stem cell transplantation","volume":"56","author":"Maung","year":"2021","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2023.10.002_bib0030","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1038\/s41409-019-0685-z","article-title":"Successful treatment of refractory CMV colitis after haploidentical HSCT with post-transplant cyclophosphamide using CD45RA+ depleted donor lymphocyte infusion","volume":"55","author":"Park","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2023.10.002_bib0031","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13023-016-0385-3","article-title":"Novel treatment of severe combined immunodeficiency utilizing ex-vivo T-cell depleted haploidentical hematopoietic stem cell transplantation and CD45RA+ depleted donor lymphocyte infusions","volume":"11","author":"Brodszki","year":"2016","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.jcyt.2023.10.002_bib0032","doi-asserted-by":"crossref","first-page":"1083215","DOI":"10.3389\/fmed.2023.1083215","article-title":"Familial CD45RA\u2212T cells to treat severe refractory infections in immunocompromised patients","volume":"19","author":"Al-Akioui-Sanz","year":"2023","journal-title":"Front. Med. (Lausanne)"},{"key":"10.1016\/j.jcyt.2023.10.002_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.101086","article-title":"Phase I dose-escalation single centre clinical trial to evaluate the safety of infusion of memory T cells as adoptive therapy in COVID-19 (RELEASE)","volume":"39","author":"P\u00e9rez-Mart\u00ednez","year":"2021","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.jcyt.2023.10.002_bib0034","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1186\/s13063-021-05625-7","article-title":"A phase I \/II dose-escalation multi-center study to evaluate the safety of infusion of natural killer cells or memory T cells as adoptive therapy in coronavirus pneumonia and\/or lymphopenia: RELEASE study protocol","volume":"22","author":"Garc\u00eda-Garc\u00eda","year":"2021","journal-title":"Trials"},{"key":"10.1016\/j.jcyt.2023.10.002_bib0035","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/s12874-020-01101-z","article-title":"Statistical design of Phase II\/III clinical trials for testing therapeutic interventions in COVID-19 patients","volume":"20","author":"Rai","year":"2020","journal-title":"BMC Med. Res. Methodol."},{"key":"10.1016\/j.jcyt.2023.10.002_bib0036","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fcell.2021.620730","article-title":"SARS-CoV-2-specific memory T lymphocytes from COVID-19 convalescent donors: identification, biobanking, and large-scale production for adoptive cell therapy","volume":"9","author":"Ferreras","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.jcyt.2023.10.002_bib0037","first-page":"599","article-title":"Simple, accurate equations for human blood 02 dissociation computations","volume":"46","author":"Severinghaus","year":"1979","journal-title":"J. Appl. Physiol. Respir. Environ. Exerc. Physiol."},{"key":"10.1016\/j.jcyt.2023.10.002_bib0038","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.chest.2016.01.003","article-title":"Nonlinear imputation of PaO2\/FIO2 from SpO2\/FIO2 among patients with acute respiratory distress syndrome","volume":"150","author":"Brown","year":"2016","journal-title":"Chest"},{"key":"10.1016\/j.jcyt.2023.10.002_bib0039","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0147-9563(98)90086-3","article-title":"Meta-analysis of arterial oxygen saturation monitoring by pulse oximetry in adults","volume":"27","author":"Jensen","year":"1998","journal-title":"Heart Lung"},{"key":"10.1016\/j.jcyt.2023.10.002_bib0040","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1136\/bmjnph-2021-000375","article-title":"Overweight and obesity as risk factors for COVID\u00ad19\u2013associated hospitalisations and death: systematic analysis review and meta-analysis","volume":"5","author":"Sawadogo","year":"2022","journal-title":"BMJ Nutr. Prev. Health"},{"key":"10.1016\/j.jcyt.2023.10.002_bib0041","doi-asserted-by":"crossref","DOI":"10.1038\/s41591-023-02480-8","article-title":"SARS-CoV-2-specific T cell therapy for severe COVID-19: a randomized phase 1\/2 trial","author":"Papadopoulou","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.jcyt.2023.10.002_bib0042","doi-asserted-by":"crossref","DOI":"10.1038\/s41591-021-01507-2","article-title":"Cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapy","author":"Apostolidis","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.jcyt.2023.10.002_bib0043","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/s41590-021-01122-w","article-title":"The T cell immune response against SARS-CoV-2","volume":"23","author":"Moss","year":"2022","journal-title":"Nat. Immunnol."},{"key":"10.1016\/j.jcyt.2023.10.002_bib0044","doi-asserted-by":"crossref","first-page":"5824","DOI":"10.1158\/1078-0432.CCR-17-0075","article-title":"Memory T cells expressing an NKG2D-CAR efficiently target osteosarcoma cells","volume":"23","author":"Fern\u00e1ndez","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jcyt.2023.10.002_bib0045","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1038\/s41409-020-01128-2","article-title":"T-cell tracking, safety, and effect of low-dose donor memory T-cell infusions after \u03b1\u03b2 T cell-depleted hematopoietic stem cell transplantation","volume":"56","author":"Blagov","year":"2021","journal-title":"Bone Marrow Transplant"},{"issue":"590","key":"10.1016\/j.jcyt.2023.10.002_bib0046","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abf7517","article-title":"T cell and antibody kinetics delineate SARS-CoV-2 peptides mediating long-term immune responses in COVID-19 convalescent individuals","volume":"13","author":"Bilich","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jcyt.2023.10.002_bib0047","doi-asserted-by":"crossref","DOI":"10.1016\/j.xcrm.2022.100562","article-title":"Count on us: T cells in SARS-CoV-2 infection and vaccination","volume":"3","author":"Kedzierska","year":"2022","journal-title":"Cell Reports Med"},{"key":"10.1016\/j.jcyt.2023.10.002_bib0048","doi-asserted-by":"crossref","unstructured":"Vardhana S, Baldo L, Ii WGM, Wherry EJ. Understanding T cell responses to COVID-19 is essential for informing public health strategies. Sci. Immunnol. 2022;7.","DOI":"10.1126\/sciimmunol.abo1303"},{"key":"10.1016\/j.jcyt.2023.10.002_bib0049","doi-asserted-by":"crossref","DOI":"10.1016\/j.xcrm.2021.100204","article-title":"Comprehensive analysis of T cell immunodominance and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 cases","volume":"2","author":"Tarke","year":"2021","journal-title":"Cell Reports Med"},{"key":"10.1016\/j.jcyt.2023.10.002_bib0050","doi-asserted-by":"crossref","first-page":"103382","DOI":"10.1016\/j.msard.2021.103382","article-title":"Humoral and T-cell responses to SARS-CoV-2 vaccination in multiple sclerosis patients treated with ocrelizumab","volume":"57","author":"Katz","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.jcyt.2023.10.002_bib0051","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fcimb.2021.765039","article-title":"Genomic variations in the structural proteins of SARS-CoV-2 and their deleterious impact on pathogenesis: a comparative genomics approach","volume":"11","author":"Mohammad","year":"2021","journal-title":"Front. Cell. Infect. Microbiol"},{"key":"10.1016\/j.jcyt.2023.10.002_bib0052","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0285728","article-title":"Assessing SARS-CoV-2\u2013specific T-cell reactivity in late convalescents and vaccinees: comparison and combination of QuantiFERON and activation-induced marker assays, and relation with antibody status","volume":"18","author":"Gatti","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.jcyt.2023.10.002_bib0053","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cytogfr.2020.06.001","article-title":"SARS-CoV-2 infection: the role of cytokines in COVID-19 disease","volume":"54","author":"Costela-Ruiz","year":"2020","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.jcyt.2023.10.002_bib0054","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/jmv.26232","article-title":"The cytokine storm and COVID-19","volume":"93","author":"Hu","year":"2021","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.jcyt.2023.10.002_bib0055","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23073673","article-title":"What is currently known about the role of CXCL10 in SARS-CoV-2 Infection?","volume":"23","author":"Gudowska-Sawczuk","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jcyt.2023.10.002_bib0056","doi-asserted-by":"crossref","DOI":"10.1186\/s10020-021-00390-4","article-title":"CXCL10 levels at hospital admission predict COVID-19 outcome: hierarchical assessment of 53 putative inflammatory biomarkers in an observational study","volume":"27","author":"Lor\u00e8","year":"2021","journal-title":"Mol. Med."},{"key":"10.1016\/j.jcyt.2023.10.002_bib0057","doi-asserted-by":"crossref","unstructured":"Kim N. et al. Off-the-shelf partial HLA matching SARS-CoV-2 antigen specific T cell therapy: a new possibility for COVID-19 treatment. Front. Immunol. 2021;12:1\u201315.","DOI":"10.3389\/fimmu.2021.751869"},{"key":"10.1016\/j.jcyt.2023.10.002_bib0058","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ebiom.2021.103789","article-title":"Human mesenchymal stem cells treatment for severe COVID-19: 1-year follow-up results of a randomized, double-blind, placebo-controlled trial","volume":"75","author":"Shi","year":"2022","journal-title":"eBioMedicine"},{"key":"10.1016\/j.jcyt.2023.10.002_bib0059","doi-asserted-by":"crossref","DOI":"10.1128\/cmr.00200-21","article-title":"COVID-19 convalescent plasma and clinical trials: understanding conflicting outcomes","volume":"35","author":"Focosi","year":"2022","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.jcyt.2023.10.002_bib0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/pnasnexus\/pgac042","article-title":"Third dose vaccination with mRNA-1273 or BNT162b2 vaccines improves protection against SARS-CoV-2 infection","volume":"1","author":"Niesen","year":"2022","journal-title":"PNAS Nexus"},{"key":"10.1016\/j.jcyt.2023.10.002_bib0061","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ijid.2020.07.029","article-title":"Comorbidities and the risk of severe or fatal outcomes associated with coronavirus disease 2019: A systematic review and meta-analysis","volume":"99","author":"Zhou","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.jcyt.2023.10.002_bib0062","doi-asserted-by":"crossref","first-page":"E132","DOI":"10.1161\/HYPERTENSIONAHA.122.19694","article-title":"Hypertension and excess risk for severe COVID-19 illness despite booster vaccination","volume":"79","author":"Ebinger","year":"2022","journal-title":"Hypertension"},{"key":"10.1016\/j.jcyt.2023.10.002_bib0063","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.3390\/jcm9061733","article-title":"A cohort of patients with COVID-19 in a major teaching hospital in Europe","volume":"9","author":"Borobia","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.jcyt.2023.10.002_bib0064","first-page":"1","article-title":"Comorbid illnesses are associated with altered adaptive immune responses to SARS-CoV-2","volume":"19","author":"Yu","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.jcyt.2023.10.002_bib0065","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1007\/s10517-013-2182-5","article-title":"Dexamethasone effects on activation and proliferation of immune memory T cells","volume":"155","author":"Gutsol","year":"2013","journal-title":"Bull. Exp. Biol. Med."},{"key":"10.1016\/j.jcyt.2023.10.002_bib0066","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40425-018-0371-5","article-title":"Dexamethasone-induced immunosuppression: mechanisms and implications for immunotherapy","volume":"6","author":"Giles","year":"2018","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.jcyt.2023.10.002_bib0067","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.jcyt.2022.12.001","article-title":"Donor selection for adoptive cell therapy with CD45RA- memory T cells for patients with coronavirus disease 2019, and dexamethasone and interleukin-15 effects on the phenotype, proliferation and interferon gamma release","volume":"25","author":"Al-Akioui","year":"2023","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2023.10.002_bib0068","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/iid3.358","article-title":"Association between HLA gene polymorphisms and mortality of COVID-19: an in silico analysis","volume":"8","author":"Tomita","year":"2020","journal-title":"Immun Inflamm Dis"},{"key":"10.1016\/j.jcyt.2023.10.002_bib0069","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.ppat.1010339","article-title":"SARS-CoV-2-specific T cells generated for adoptive immunotherapy are capable of recognizing multiple SARS-CoV-2 variants","volume":"18","author":"Panikkar","year":"2022","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jcyt.2023.10.002_bib0070","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/tan.13941","article-title":"Distribution of HLA allele frequencies in 82 Chinese individuals with coronavirus disease-2019 (COVID-19)","volume":"96","author":"Wang","year":"2020","journal-title":"HLA"},{"key":"10.1016\/j.jcyt.2023.10.002_bib0071","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s41232-022-00242-6","article-title":"Current understanding of T cell immunity against SARS-CoV-2","volume":"42","author":"Lu","year":"2022","journal-title":"Inflamm. Regen."},{"key":"10.1016\/j.jcyt.2023.10.002_bib0072","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1056\/NEJMoa2020283","article-title":", et al. Genomewide association study of severe Covid-19 with respiratory failure","volume":"383","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jcyt.2023.10.002_bib0073","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/tan.14284","article-title":"The influence of HLA genotype on the severity of COVID-19 infection","volume":"98","author":"Langton","year":"2021","journal-title":"HLA"},{"key":"10.1016\/j.jcyt.2023.10.002_bib0074","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41590-020-00808-x","article-title":"SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition","volume":"22","author":"Nelde","year":"2021","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jcyt.2023.10.002_bib0075","article-title":"SARS-CoV-2 infection","volume":"76","author":"Augusto","year":"2022","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.jcyt.2023.10.002_bib0076","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2020.00827","article-title":"Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19)","volume":"11","author":"Diao","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jcyt.2023.10.002_bib0077","article-title":"Dysregulation of immune response in patients with COVID-19 in Wuhan, China","author":"Qin","year":"2020","journal-title":"SSRN Electron. J"},{"key":"10.1016\/j.jcyt.2023.10.002_bib0078","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ijid.2020.04.086","article-title":"Lymphopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: a systemic review and meta-analysis","volume":"96","author":"Zhao","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.jcyt.2023.10.002_bib0079","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/sji.12967","article-title":"Lymphopenia an important immunological abnormality in patients with COVID-19: possible mechanisms","volume":"93","author":"Jafarzadeh","year":"2021","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.jcyt.2023.10.002_bib0080","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3390\/idr14010003","article-title":"Pre-existing lymphopenia increases the risk of hospitalization and death after SARS-CoV-2 infection","volume":"14","author":"Garbo","year":"2022","journal-title":"Infect. Dis. Rep."},{"key":"10.1016\/j.jcyt.2023.10.002_bib0081","doi-asserted-by":"crossref","first-page":"700","DOI":"10.3390\/jcm11030700","article-title":"Lymphopenia as a predictor for adverse clinical outcomes in hospitalized patients with COVID-19\u202f: a single center retrospective study of 4485 cases","volume":"11","author":"Niu","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.jcyt.2023.10.002_bib0082","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.crimmu.2022.08.005","article-title":"Current research in immunology from alpha to omicron: the response of T cells","volume":"3","author":"Grifoni","year":"2022","journal-title":"Curr. Res. Immunol."},{"key":"10.1016\/j.jcyt.2023.10.002_bib0083","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1473-3099(22)00831-3","article-title":"Neutralisation sensitivity of the SARS-CoV-2 XBB.1 lineage","volume":"23","author":"Arora","year":"2023","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.jcyt.2023.10.002_bib0084","first-page":"1","article-title":"Clinical management of patients with b-cell depletion agents to treat or prevent prolonged and severe SARS-COV-2 infection: defining a treatment pathway","volume":"13","author":"D'Abramo","year":"2022","journal-title":"Front. Immunol."}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324923010563?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324923010563?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T01:51:42Z","timestamp":1761443502000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324923010563"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":84,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S1465324923010563"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2023.10.002","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Results of phase 2 randomized multi-center study to evaluate the safety and efficacy of infusion of memory T cells as adoptive therapy in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia and\/or lymphopenia (RELEASE NCT04578210)","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2023.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 International Society for Cell & Gene Therapy. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}